Latest filing published 11 Feb 2025 for Marinus Pharmaceuticals, INC., €9,944.
Christina Shafer appears in our data through filings on Marinus Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 9 November 2022 to 11 February 2025, the count stands at 10 filings.
On the market, this insider has only sold: 4 sales, €44k in total. Outside the open market, there are 4 share grants.
The latest filing, published on 11 February 2025, reports a transaction of €26k in Marinus Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations